| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adrenergic mechanisms in multiple sclerosis: the neuro–immune connection?
|
Cosentino, Marco
|
|
2004
|
25 |
7 |
p. 350-351
2 p.
|
artikel
|
| 2 |
Anandamide hydrolase: a guardian angel of human reproduction?
|
Maccarrone, Mauro
|
|
2004
|
25 |
7 |
p. 353-357
5 p.
|
artikel
|
| 3 |
Contents page + Editorial Board
|
|
|
2004
|
25 |
7 |
p. i-
1 p.
|
artikel
|
| 4 |
Historical techniques: Cytosolic Ca2+ and contraction in smooth muscle
|
Karaki, Hideaki
|
|
2004
|
25 |
7 |
p. 388-393
6 p.
|
artikel
|
| 5 |
Human pharmacological MRI
|
Honey, Garry
|
|
2004
|
25 |
7 |
p. 366-374
9 p.
|
artikel
|
| 6 |
No value in chronological classification of COX inhibitors
|
Bakhle, Y.S
|
|
2004
|
25 |
7 |
p. 348-349
2 p.
|
artikel
|
| 7 |
Polyspecific organic cation transporters: their functions and interactions with drugs
|
Koepsell, Hermann
|
|
2004
|
25 |
7 |
p. 375-381
7 p.
|
artikel
|
| 8 |
Response to Bakhle: Coxibs are NSAIDs that can selectively inhibit COX-2…but they are not the only ones
|
Bianchi, Mauro
|
|
2004
|
25 |
7 |
p. 349-350
2 p.
|
artikel
|
| 9 |
Response to Cosentino et al.: β2-Adrenoceptors in multiple sclerosis
|
Keyser, Jacques De
|
|
2004
|
25 |
7 |
p. 351-352
2 p.
|
artikel
|
| 10 |
Small-molecule inhibitors of the p53 suppressor HDM2: have protein–protein interactions come of age as drug targets?
|
Fischer, Peter M
|
|
2004
|
25 |
7 |
p. 343-346
4 p.
|
artikel
|
| 11 |
Subtype-specific β-adrenoceptor signaling pathways in the heart and their potential clinical implications
|
Xiao, Rui-Ping
|
|
2004
|
25 |
7 |
p. 358-365
8 p.
|
artikel
|
| 12 |
Techniques: New approaches to the delivery of biopharmaceuticals
|
Orive, Gorka
|
|
2004
|
25 |
7 |
p. 382-387
6 p.
|
artikel
|
| 13 |
The National Institute for Clinical Excellence and its relevance to pharmacology
|
Kerwin, Robert
|
|
2004
|
25 |
7 |
p. 346-348
3 p.
|
artikel
|
Tijdschrift beschrijving